A detailed history of Telemetry Investments, L.L.C. transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 624,000 shares of LIFE stock, worth $1.16 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares
624,000
Previous 492,500 26.7%
Holding current value
$1.16 Million
Previous $1.48 Million 7.51%
% of portfolio
2.16%
Previous 1.89%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$2.02 - $2.49 $265,630 - $327,435
131,500 Added 26.7%
624,000 $1.37 Million
Q3 2022

Nov 17, 2022

BUY
$2.79 - $4.15 $126,945 - $188,825
45,500 Added 10.18%
492,500 $1.48 Million
Q2 2022

Aug 15, 2022

BUY
$2.63 - $5.61 $432,845 - $923,293
164,580 Added 58.27%
447,000 $1.27 Million
Q1 2022

May 16, 2022

BUY
$4.75 - $7.54 $501,780 - $796,510
105,638 Added 59.76%
282,420 $1.51 Million
Q4 2021

Feb 14, 2022

BUY
$7.29 - $9.5 $83,572 - $108,908
11,464 Added 6.93%
176,782 $1.32 Million
Q3 2021

Nov 15, 2021

SELL
$4.22 - $12.48 $59,037 - $174,595
-13,990 Reduced 7.8%
165,318 $1.5 Million
Q2 2021

Aug 16, 2021

BUY
$3.62 - $4.88 $221,138 - $298,109
61,088 Added 51.67%
179,308 $875,000
Q1 2021

May 17, 2021

BUY
$3.53 - $8.06 $417,316 - $952,853
118,220 New
118,220 $526,000

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.